Company Search:
Advanced Search
Sponsored Links
Silence Therapeutics Plc Company Snapshot
Silence Therapeutics Plc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Silence Therapeutics Plc with three other companies in this sector in UNITED KINGDOM : 4d Pharma Plc (2019 sales of £211,000.00 [US$273,316.74 ] of which 100% was ies), Immupharma PLC (£77,925.00 [US$100,939.37 ] of which 100% was Pharmaceutical Research & Development), and Reneuron Group PLC (£49,000.00 [US$63,471.66 ] of which 100% was Cell-Based Therapies).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Silence Therapeutics Plc
  Stock Performance Chart for Silence Therapeutics Plc
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 391.00p
(Figures in Pounds Sterling)
1 Week -2.3%   13 Weeks -15.6%  
4 Weeks -11.1%   52 Weeks 52.7%  
Silence Therapeutics Plc Key Data:
  Ticker: SLN Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 244,000
(Year Ending Jan 2020).
Employees: 46
  Currency: Pounds Sterling Market Cap: 323,850,673
  Fiscal Yr Ends: December Shares Outstanding: 82,826,259
  Share Type: Ordinary Closely Held Shares: 56,053,598
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.